SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Archit Organosys informs about disclosure

16 Sep 2022 Evaluate
With regards to the expansion/diversification, with regards to backward and forward integration at the Company's existing factory plot located at Bhavnagar and also at Naroda GIDC, Ahmedabad, Archit Organosys has informed that the expansion projects are now fully operational in Bhanvagar unit and stabilized. The Company expects to start yielding favourable results from the same. Taking note of the various available business opportunities in the Chemical sector in India, in which Company operates, the management of Company has charted out growth plan. The futuristic vision of management to expand and diversify into a new product ranges will be synergizing its present business and also placing Company into an accelerated trajectory of the next level of the business growth. Over a period of next few years, the Company is planning to invest around Rs 60 Crores in products like (Ethyl Acetate, Butyl Acetate, Propyl Acetate and Acetaldehyde) into the new projects which will also support the Atmanirbhar Bharat Abhiyan. The said new project will be undertaken in the recently incorporated Wholly Owned Subsidiary company namely, Archit Life Science. The new company will have advantages in terms of concessional Income tax rate. The Diversification project in new company is at initial stage and once the same is finalised the required details will be furnished. The new projects will accelerate to increase the revenue and profitability for the Company during the forthcoming years which will be further enhancing the stakeholders' value.

The above information is a part of company’s filings submitted to BSE.

Archit Organosys Share Price

54.21 0.43 (0.80%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3649.20
Tata Chemicals 694.10
SRF 2493.90
Pidilite Inds. 1394.35
Deepak Nitrite 1690.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×